Open Access

About the speaker

Doctor Gemma Vilahur

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
9 presentations
0 follower

4 more presentations in this session

Dual anti platelet therapy duration? Very short or very long?

Speaker: Professor J. ten Berg (Nieuwegein, NL)


De-escalation of monotherapy with P2Y12 inhibitor. An alternative approach.

Speaker: Doctor J. Ferreiro (Hospitalet De Llobregat, ES)


Very low dose of rivaroxaban. It is time for a new era.

Speaker: Professor J. Morais (Leiria, PT)


The bleeding risk the true game changer.

Speaker: Professor T. Geisler (Tuebingen, DE)


Access the full session

Welcome and Session 1: From ACS to chronic coronary artery disease. The transition period

Speakers: Doctor G. Vilahur, Professor J. ten Berg, Doctor J. Ferreiro, Professor J. Morais, Professor T. Geisler

About the event


Hot topics and new insights for Thrombosis 2022

17 March 2022 17:00 CET

ESC 365 is supported by

logo Novo Nordisk